Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Cash from Financing Activities (2019 - 2025)

Historic Cash from Financing Activities for BioScience Health Innovations (BHIC) over the last 7 years, with Q3 2025 value amounting to $180461.0.

  • BioScience Health Innovations' Cash from Financing Activities rose 2523.14% to $180461.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $648698.0, marking a year-over-year increase of 13066.21%. This contributed to the annual value of $646128.0 for FY2024, which is 10478.78% up from last year.
  • Latest data reveals that BioScience Health Innovations reported Cash from Financing Activities of $180461.0 as of Q3 2025, which was up 2523.14% from $2119.0 recorded in Q2 2025.
  • BioScience Health Innovations' Cash from Financing Activities' 5-year high stood at $398602.0 during Q4 2024, with a 5-year trough of -$18313.0 in Q2 2024.
  • Moreover, its 5-year median value for Cash from Financing Activities was $67516.0 (2025), whereas its average is $90838.7.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first soared by 138384.62% in 2021, then plummeted by 11354.64% in 2024.
  • BioScience Health Innovations' Cash from Financing Activities (Quarter) stood at $100000.0 in 2021, then tumbled by 60.0% to $40000.0 in 2022, then fell by 15.73% to $33707.0 in 2023, then soared by 1082.55% to $398602.0 in 2024, then crashed by 54.73% to $180461.0 in 2025.
  • Its last three reported values are $180461.0 in Q3 2025, $2119.0 for Q2 2025, and $67516.0 during Q1 2025.